Cao, Zhaoming
Chen, Yufu
Zhang, Huijun
Article History
Received: 28 November 2022
Accepted: 1 October 2023
First Online: 16 October 2023
Declarations
:
: Participants were informed of the purpose and methods of the study, the risks and benefits of participation, the confidentiality of their data, and the voluntary nature of participation. Written informed consent was obtained before the interviews for item development and refinement. The return of the completed anonymous questionnaire was taken as consent to participate in the main study. The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Jinzhou Medical University (no. KYLL202127).
: We declare that we have no conflict of interest.